Global Xerophthalmia Treatment Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Xerophthalmia Treatment market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerophthalmia Treatment development in United States, Europe and China.
    
    The key players covered in this study
        Allergan Plc
        Novartis AG
        Otsuka Pharmaceutical Co.,Ltd.
        Abbott Laboratories
        Santen Pharmaceutical Co Ltd
        Valent Pharmaceuticals
        Akorn, Inc
        Shire Plc
        Thea Pharmaceuticals Limited
        OASIS Medical
        Altaire Pharmaceuticals Inc
        Boiron USA
        Similasan Corporation
        Scope Ophthalmics Ltd.
        Reckitt Benckiser Group PLC
        Medicom Healthcare Ltd
        FDC Limited
        Lupin Limited
        Jamjoom Pharmaceuticals Co.
        Sentiss Pharma Private limited
    
    Market segment by Type, the product can be split into
        Cyclosporin
        Oral Corticosteroids
        Artificial Tears
        Punctal Plugs
        Omega Supplements
        Others
    
    Market segment by Application, split into
        Hospital Pharmacies
        Eye Health Clinics
        Retail Pharmacies
        Online Pharmacies
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players.
        To present the Xerophthalmia Treatment development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Xerophthalmia Treatment are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Xerophthalmia Treatment Market Size Growth Rate by Type (2013-2025)
            1.4.2 Cyclosporin
            1.4.3 Oral Corticosteroids
            1.4.4 Artificial Tears
            1.4.5 Punctal Plugs
            1.4.6 Omega Supplements
            1.4.7 Others
        1.5 Market by Application
            1.5.1 Global Xerophthalmia Treatment Market Share by Application (2013-2025)
            1.5.2 Hospital Pharmacies
            1.5.3 Eye Health Clinics
            1.5.4 Retail Pharmacies
            1.5.5 Online Pharmacies
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Xerophthalmia Treatment Market Size
        2.2 Xerophthalmia Treatment Growth Trends by Regions
            2.2.1 Xerophthalmia Treatment Market Size by Regions (2013-2025)
            2.2.2 Xerophthalmia Treatment Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Xerophthalmia Treatment Market Size by Manufacturers
            3.1.1 Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018)
            3.1.2 Global Xerophthalmia Treatment Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Xerophthalmia Treatment Market Concentration Ratio (CR5 and HHI)
        3.2 Xerophthalmia Treatment Key Players Head office and Area Served
        3.3 Key Players Xerophthalmia Treatment Product/Solution/Service
        3.4 Date of Enter into Xerophthalmia Treatment Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Xerophthalmia Treatment Market Size by Type (2013-2018)
        4.2 Global Xerophthalmia Treatment Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Xerophthalmia Treatment Market Size (2013-2018)
        5.2 Xerophthalmia Treatment Key Players in United States
        5.3 United States Xerophthalmia Treatment Market Size by Type
        5.4 United States Xerophthalmia Treatment Market Size by Application
    
    6 Europe
        6.1 Europe Xerophthalmia Treatment Market Size (2013-2018)
        6.2 Xerophthalmia Treatment Key Players in Europe
        6.3 Europe Xerophthalmia Treatment Market Size by Type
        6.4 Europe Xerophthalmia Treatment Market Size by Application
    
    7 China
        7.1 China Xerophthalmia Treatment Market Size (2013-2018)
        7.2 Xerophthalmia Treatment Key Players in China
        7.3 China Xerophthalmia Treatment Market Size by Type
        7.4 China Xerophthalmia Treatment Market Size by Application
    
    8 Japan
        8.1 Japan Xerophthalmia Treatment Market Size (2013-2018)
        8.2 Xerophthalmia Treatment Key Players in Japan
        8.3 Japan Xerophthalmia Treatment Market Size by Type
        8.4 Japan Xerophthalmia Treatment Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Xerophthalmia Treatment Market Size (2013-2018)
        9.2 Xerophthalmia Treatment Key Players in Southeast Asia
        9.3 Southeast Asia Xerophthalmia Treatment Market Size by Type
        9.4 Southeast Asia Xerophthalmia Treatment Market Size by Application
    
    10 India
        10.1 India Xerophthalmia Treatment Market Size (2013-2018)
        10.2 Xerophthalmia Treatment Key Players in India
        10.3 India Xerophthalmia Treatment Market Size by Type
        10.4 India Xerophthalmia Treatment Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Xerophthalmia Treatment Market Size (2013-2018)
        11.2 Xerophthalmia Treatment Key Players in Central & South America
        11.3 Central & South America Xerophthalmia Treatment Market Size by Type
        11.4 Central & South America Xerophthalmia Treatment Market Size by Application
    
    12 International Players Profiles
        12.1 Allergan Plc
            12.1.1 Allergan Plc Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Xerophthalmia Treatment Introduction
            12.1.4 Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.1.5 Allergan Plc Recent Development
        12.2 Novartis AG
            12.2.1 Novartis AG Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Xerophthalmia Treatment Introduction
            12.2.4 Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.2.5 Novartis AG Recent Development
        12.3 Otsuka Pharmaceutical Co.,Ltd.
            12.3.1 Otsuka Pharmaceutical Co.,Ltd. Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Xerophthalmia Treatment Introduction
            12.3.4 Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.3.5 Otsuka Pharmaceutical Co.,Ltd. Recent Development
        12.4 Abbott Laboratories
            12.4.1 Abbott Laboratories Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Xerophthalmia Treatment Introduction
            12.4.4 Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.4.5 Abbott Laboratories Recent Development
        12.5 Santen Pharmaceutical Co Ltd
            12.5.1 Santen Pharmaceutical Co Ltd Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Xerophthalmia Treatment Introduction
            12.5.4 Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.5.5 Santen Pharmaceutical Co Ltd Recent Development
        12.6 Valent Pharmaceuticals
            12.6.1 Valent Pharmaceuticals Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Xerophthalmia Treatment Introduction
            12.6.4 Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.6.5 Valent Pharmaceuticals Recent Development
        12.7 Akorn, Inc
            12.7.1 Akorn, Inc Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Xerophthalmia Treatment Introduction
            12.7.4 Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.7.5 Akorn, Inc Recent Development
        12.8 Shire Plc
            12.8.1 Shire Plc Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Xerophthalmia Treatment Introduction
            12.8.4 Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.8.5 Shire Plc Recent Development
        12.9 Thea Pharmaceuticals Limited
            12.9.1 Thea Pharmaceuticals Limited Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Xerophthalmia Treatment Introduction
            12.9.4 Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.9.5 Thea Pharmaceuticals Limited Recent Development
        12.10 OASIS Medical
            12.10.1 OASIS Medical Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Xerophthalmia Treatment Introduction
            12.10.4 OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)
            12.10.5 OASIS Medical Recent Development
        12.11 Altaire Pharmaceuticals Inc
        12.12 Boiron USA
        12.13 Similasan Corporation
        12.14 Scope Ophthalmics Ltd.
        12.15 Reckitt Benckiser Group PLC
        12.16 Medicom Healthcare Ltd
        12.17 FDC Limited
        12.18 Lupin Limited
        12.19 Jamjoom Pharmaceuticals Co.
        12.20 Sentiss Pharma Private limited
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Xerophthalmia Treatment Key Market Segments
        Table Key Players Xerophthalmia Treatment Covered
        Table Global Xerophthalmia Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Xerophthalmia Treatment Market Size Market Share by Type 2013-2025
        Figure Cyclosporin Figures
        Table Key Players of Cyclosporin
        Figure Oral Corticosteroids Figures
        Table Key Players of Oral Corticosteroids
        Figure Artificial Tears Figures
        Table Key Players of Artificial Tears
        Figure Punctal Plugs Figures
        Table Key Players of Punctal Plugs
        Figure Omega Supplements Figures
        Table Key Players of Omega Supplements
        Figure Others Figures
        Table Key Players of Others
        Table Global Xerophthalmia Treatment Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Pharmacies Case Studies
        Figure Eye Health Clinics Case Studies
        Figure Retail Pharmacies Case Studies
        Figure Online Pharmacies Case Studies
        Figure Xerophthalmia Treatment Report Years Considered
        Table Global Xerophthalmia Treatment Market Size 2013-2025 (Million US$)
        Figure Global Xerophthalmia Treatment Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Xerophthalmia Treatment Market Size by Regions 2013-2025 (Million US$)
        Table Global Xerophthalmia Treatment Market Size by Regions 2013-2018 (Million US$)
        Table Global Xerophthalmia Treatment Market Share by Regions 2013-2018
        Figure Global Xerophthalmia Treatment Market Share by Regions 2013-2018
        Figure Global Xerophthalmia Treatment Market Share by Regions 2018
        Table Market Top Trends
        Table Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Xerophthalmia Treatment Market Share by Manufacturers (2013-2018)
        Figure Global Xerophthalmia Treatment Market Share by Manufacturers in 2018
        Table Global Xerophthalmia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Xerophthalmia Treatment Product/Solution/Service
        Table Date of Enter into Xerophthalmia Treatment Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table Global Xerophthalmia Treatment Market Size Share by Type (2013-2018)
        Figure Global Xerophthalmia Treatment Market Size Market Share by Type (2013-2018)
        Table Global Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table Global Xerophthalmia Treatment Market Size Share by Application (2013-2018)
        Figure Global Xerophthalmia Treatment Market Size Market Share by Application (2013-2018)
        Figure Global Xerophthalmia Treatment Revenue Market Share by Application in 2017
        Figure United States Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table United States Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table United States Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table United States Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table United States Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table United States Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table United States Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure Europe Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table Europe Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table Europe Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table Europe Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table Europe Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table Europe Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table Europe Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure China Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table China Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table China Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table China Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table China Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table China Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table China Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure Japan Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table Japan Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table Japan Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table Japan Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table Japan Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table Japan Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table Japan Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure Southeast Asia Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table Southeast Asia Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table Southeast Asia Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure India Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table India Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table India Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table India Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table India Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table India Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table India Xerophthalmia Treatment Market Share by Application (2013-2018)
        Figure Central & South America Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Xerophthalmia Treatment Market Share (2017-2018)
        Table Central & South America Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Xerophthalmia Treatment Market Share by Type (2013-2018)
        Table Central & South America Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Xerophthalmia Treatment Market Share by Application (2013-2018)
        Table Allergan Plc Company Details
        Table Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018) (Million US$)
        Figure Allergan Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Allergan Plc Recent Development
        Table Novartis AG Company Details
        Table Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Novartis AG Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Novartis AG Recent Development
        Table Otsuka Pharmaceutical Co.,Ltd. Company Details
        Table Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Otsuka Pharmaceutical Co.,Ltd. Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Otsuka Pharmaceutical Co.,Ltd. Recent Development
        Table Abbott Laboratories Company Details
        Table Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Abbott Laboratories Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Abbott Laboratories Recent Development
        Table Santen Pharmaceutical Co Ltd Company Details
        Table Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Santen Pharmaceutical Co Ltd Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Santen Pharmaceutical Co Ltd Recent Development
        Table Valent Pharmaceuticals Company Details
        Table Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Valent Pharmaceuticals Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Valent Pharmaceuticals Recent Development
        Table Akorn, Inc Company Details
        Table Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Akorn, Inc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Akorn, Inc Recent Development
        Table Shire Plc Company Details
        Table Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Shire Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Shire Plc Recent Development
        Table Thea Pharmaceuticals Limited Company Details
        Table Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure Thea Pharmaceuticals Limited Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table Thea Pharmaceuticals Limited Recent Development
        Table OASIS Medical Company Details
        Table OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
        Figure OASIS Medical Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
        Table OASIS Medical Recent Development
        Table Altaire Pharmaceuticals Inc Company Details
        Table Boiron USA Company Details
        Table Similasan Corporation Company Details
        Table Scope Ophthalmics Ltd. Company Details
        Table Reckitt Benckiser Group PLC Company Details
        Table Medicom Healthcare Ltd Company Details
        Table FDC Limited Company Details
        Table Lupin Limited Company Details
        Table Jamjoom Pharmaceuticals Co. Company Details
        Table Sentiss Pharma Private limited Company Details
        Table Global Xerophthalmia Treatment Market Size by Regions (Million US$) 2018-2025
        Figure Global Xerophthalmia Treatment Market Size Share by Regions (2018-2025)
        Figure Global Xerophthalmia Treatment Market Size Share by Regions in 2025
        Figure United States Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure China Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure India Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
        Table Global Xerophthalmia Treatment Market Size by Product (2018-2025) (Million US$)
        Figure Global Xerophthalmia Treatment Market Size by Product (2018-2025)
        Figure Global Xerophthalmia Treatment Market Size by Product in 2025
        Table Global Xerophthalmia Treatment Market Size by Application (2018-2025) (Million US$)
        Figure Global Xerophthalmia Treatment Market Size by Application (2018-2025)
        Figure Global Xerophthalmia Treatment Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources